Artivion | CRY - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.3B 380M 2026-03
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 31.94M 3.22M 2026-03
Baxter International USD 1.81B 587M 2026-03
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.83B 8M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Inogen USD 39.59M 1.27M 2024-09
Integra LifeSciences USD 178.71M 14.73M 2026-03
J&J USD 8.07B 103M 2026-03
Mesa Laboratories USD 21.92M 1.78M 2024-09
Orthofix International USD 66.63M 6.4M 2025-12
Pfizer USD 4.59B 1.7B 2026-03
ResMed USD 551.67M 4.17M 2026-03
Stryker USD 2.36B 325M 2026-03
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
Terumo JPY 151.3B 7.86B 2026-03
Trinity Biotech USD 7.17M 666K 2025-12